Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Partially Blind, Placebo Controlled, Randomized, Combined Single Ascending Dose
with a Food Effect Cohort (Part 1) and Multiple Ascending Dose Study (Part 2) Study to
Evaluate the Safety, Tolerability, and Pharmacokinetics of TBAJ-876 in Healthy Adult Subjects